Rare diseases
Investigational molecules
Locations
1275 York Avenue, 10065-6007, United States
Research activity includes unresectable intrahepatic cholangiocarcinoma and other bile duct cancer presentations involving liver-confined disease.
The therapeutic emphasis is on combining regional liver-directed treatment with systemic regimens for advanced hepatobiliary malignancies.
Memorial Sloan Kettering Cancer Center runs clinical trials in conditions such as Cholangiocarcinoma, Hormone-refractory prostate cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
The NetherlandsThe NetherlandsIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
